Reversal of social deficits by subchronic oxytocin in two autism mouse models.
about
Communication Impairment in Ultrasonic Vocal Repertoire during the Suckling Period of Cd157 Knockout Mice: Transient Improvement by Oxytocin.Oxytocin and Animal Models for Autism Spectrum Disorder.Genetic and Pharmacological Reversibility of Phenotypes in Mouse Models of Autism Spectrum Disorder.Risperidone and aripiprazole alleviate prenatal valproic acid-induced abnormalities in behaviors and dendritic spine density in mice.Neonatal Oxytocin Treatment Ameliorates Autistic-Like Behaviors and Oxytocin Deficiency in Valproic Acid-Induced Rat Model of AutismCritical roles of serotonin-oxytocin interaction during the neonatal period in social behavior in 15q dup mice with autistic traits
P2860
Reversal of social deficits by subchronic oxytocin in two autism mouse models.
description
2015 nî lūn-bûn
@nan
2015 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Reversal of social deficits by subchronic oxytocin in two autism mouse models
@nl
Reversal of social deficits by subchronic oxytocin in two autism mouse models.
@ast
Reversal of social deficits by subchronic oxytocin in two autism mouse models.
@en
type
label
Reversal of social deficits by subchronic oxytocin in two autism mouse models
@nl
Reversal of social deficits by subchronic oxytocin in two autism mouse models.
@ast
Reversal of social deficits by subchronic oxytocin in two autism mouse models.
@en
prefLabel
Reversal of social deficits by subchronic oxytocin in two autism mouse models
@nl
Reversal of social deficits by subchronic oxytocin in two autism mouse models.
@ast
Reversal of social deficits by subchronic oxytocin in two autism mouse models.
@en
P2093
P2860
P50
P1433
P1476
Reversal of social deficits by subchronic oxytocin in two autism mouse models.
@en
P2093
Beverly H Koller
Cort A Pedersen
Kara L Agster
Michael B Jarstfer
Natallia V Riddick
Sheryl S Moy
Viktoriya D Nikolova
P2860
P356
10.1016/J.NEUROPHARM.2015.12.025
P407
P577
2015-12-31T00:00:00Z